To explore potential candidate drug molecules for BC treatment from a collection of 198 published drugs, molecular docking analysis was performed using our identified bKGs-mediated proteins (pykA, mdh, pgi, pykF, zwf, gapA, pfkA, pgk, tpiA, and ppsA) as receptors. Here, PFKM is linked to breast cancer.